Edwards Lifesciences Corporation (ETR:EWL)
Germany
· Delayed Price · Currency is EUR 61.20
-0.13 (-0.21%)
Last updated: Apr 15, 2025
Edwards Lifesciences Revenue
In the year 2024, Edwards Lifesciences had annual revenue of $5.44B USD with 8.57% growth. Edwards Lifesciences had revenue of $1.39B in the quarter ending December 31, 2024, with 9.43% growth.
Revenue
$5.44B
Revenue Growth
+8.57%
P/S Ratio
6.97
Revenue / Employee
$344.27K
Employees
15,800
Market Cap
36.63B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.44B | 429.50M | 8.57% |
| Dec 31, 2023 | 5.01B | 546.00M | 12.23% |
| Dec 31, 2022 | 4.46B | -768.50M | -14.69% |
| Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
| Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 34.18B |
| Deutsche Telekom AG | 118.43B |
| Siemens Aktiengesellschaft | 76.54B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Merck KGaA | 21.16B |
| Deutsche Börse AG | 5.80B |